NO20002279D0 - Sammensetninger av lipidsenkende midler - Google Patents

Sammensetninger av lipidsenkende midler

Info

Publication number
NO20002279D0
NO20002279D0 NO20002279A NO20002279A NO20002279D0 NO 20002279 D0 NO20002279 D0 NO 20002279D0 NO 20002279 A NO20002279 A NO 20002279A NO 20002279 A NO20002279 A NO 20002279A NO 20002279 D0 NO20002279 D0 NO 20002279D0
Authority
NO
Norway
Prior art keywords
lipid
compositions
lowering agents
lowering
agents
Prior art date
Application number
NO20002279A
Other languages
English (en)
Other versions
NO20002279L (no
Inventor
Lieven Baert
Geert Verreck
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20002279D0 publication Critical patent/NO20002279D0/no
Publication of NO20002279L publication Critical patent/NO20002279L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
NO20002279A 1997-11-03 2000-04-28 Sammensetninger av lipidsenkende midler NO20002279L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203407 1997-11-03
PCT/EP1998/006998 WO1999022738A1 (en) 1997-11-03 1998-10-27 Compositions of lipid lowering agents

Publications (2)

Publication Number Publication Date
NO20002279D0 true NO20002279D0 (no) 2000-04-28
NO20002279L NO20002279L (no) 2000-04-28

Family

ID=8228898

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002279A NO20002279L (no) 1997-11-03 2000-04-28 Sammensetninger av lipidsenkende midler

Country Status (20)

Country Link
US (1) US6342245B1 (no)
EP (1) EP1028730B1 (no)
JP (1) JP2001521899A (no)
KR (2) KR20010023661A (no)
CN (1) CN1278175A (no)
AR (1) AR013739A1 (no)
AT (1) ATE216238T1 (no)
AU (1) AU746890B2 (no)
BG (1) BG104338A (no)
BR (1) BR9814109A (no)
CA (1) CA2307097A1 (no)
DE (1) DE69804994D1 (no)
EE (1) EE200000186A (no)
HU (1) HUP0004139A3 (no)
NO (1) NO20002279L (no)
NZ (1) NZ503413A (no)
PL (1) PL340305A1 (no)
SK (1) SK5972000A3 (no)
WO (1) WO1999022738A1 (no)
ZA (1) ZA989997B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004534812A (ja) 2001-06-22 2004-11-18 ファイザー・プロダクツ・インク 薬物および中性ポリマーの分散物の医薬組成物
US20030059487A1 (en) * 2001-09-21 2003-03-27 Niazi Sarfaraz K. Composition and method for the treatment of hypercholesterolemia and hyperlipidemia in mammals
US20040220240A1 (en) * 2001-11-28 2004-11-04 Pellegrini Cara A. Method of increasing the extent of absorption of tizanidine
US6455557B1 (en) * 2001-11-28 2002-09-24 Elan Pharmaceuticals, Inc. Method of reducing somnolence in patients treated with tizanidine
NZ546183A (en) * 2003-09-26 2011-04-29 Alza Corp Controlled release formulations exhibiting an ascending rate of release
NZ546148A (en) 2003-09-26 2009-05-31 Alza Corp Drug coating providing high drug loading and methods for providing the same
JP5563731B2 (ja) * 2003-09-26 2014-07-30 アルザ・コーポレーシヨン オピオイドおよび非オピオイド鎮痛薬の制御放出製剤
MXPA06003453A (es) * 2003-09-26 2006-08-31 Johnson & Johnson Barra de empuje oros para el suministro controlado de agentes activos.
PL1683524T3 (pl) 2003-11-14 2011-06-30 Ea Pharma Co Ltd Stała dyspersja lub preparat farmaceutyczny stałej dyspersji pochodnej fenyloalaniny
CA2562015A1 (en) * 2004-04-09 2005-10-20 Janssen Pharmaceutica Nv Intermittent dosing regimens of apob secretion/mtp inhibitors for overweith and obese subjects
WO2005117834A1 (en) * 2004-05-27 2005-12-15 Janssen Pharmaceutica N.V. Solid dispersions of a basic drug compound and a polymer containing acidic groups
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
KR100582347B1 (ko) * 2004-12-30 2006-05-22 한미약품 주식회사 3-하이드록시-3-메틸글루타릴 조효소 ａ 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법
WO2006129193A2 (en) * 2005-05-27 2006-12-07 Pfizer Products Inc. Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss
JP2009504590A (ja) * 2005-08-08 2009-02-05 アボット ゲーエムベーハー ウント コンパニー カーゲー 改善された生物学的利用能をもつ剤型
EP1938804A1 (en) * 2006-12-22 2008-07-02 Novartis AG Pharmaceutical formulation comprising neurokinin antagonist
DE102008047910A1 (de) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tablettierhilfsstoff auf Laktose- und Cellulosebasis
WO2010143199A1 (en) 2009-06-11 2010-12-16 Suven Nishtaa Pharma Private Limited Solid lipid dispersion for aqueous solubility enhancement of poorly water soluble drugs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100227231B1 (ko) * 1994-10-27 1999-11-01 디르크 반테 아포리포프로테인-b 합성 억제제
US5521186A (en) * 1994-10-27 1996-05-28 Janssen Pharmaceutica N.V. Apolipoprotein-β synthesis inhibitors

Also Published As

Publication number Publication date
BG104338A (en) 2000-12-29
SK5972000A3 (en) 2000-12-11
CA2307097A1 (en) 1999-05-14
HUP0004139A3 (en) 2002-03-28
BR9814109A (pt) 2000-10-03
AU746890B2 (en) 2002-05-02
PL340305A1 (en) 2001-01-29
KR20010023729A (ko) 2001-03-26
AR013739A1 (es) 2001-01-10
DE69804994D1 (de) 2002-05-23
CN1278175A (zh) 2000-12-27
EP1028730B1 (en) 2002-04-17
JP2001521899A (ja) 2001-11-13
HUP0004139A2 (hu) 2002-02-28
EE200000186A (et) 2001-04-16
WO1999022738A1 (en) 1999-05-14
NO20002279L (no) 2000-04-28
US6342245B1 (en) 2002-01-29
AU1157699A (en) 1999-05-24
NZ503413A (en) 2001-06-29
ZA989997B (en) 2000-05-02
ATE216238T1 (de) 2002-05-15
KR20010023661A (ko) 2001-03-26
EP1028730A1 (en) 2000-08-23

Similar Documents

Publication Publication Date Title
ID22931A (id) Komposisi-komposisi herbisidal
ID22970A (id) Komposisi perekat
DE69832516D1 (de) Isoflavon-enthaltende zusammensetzungen
DK1298194T3 (da) Staniolholdige sammensætninger
DE69811436D1 (de) Verbesserte Verarbeitbarkeit von Silica-gefüllten Kautschukzusammensetzungen
PT945132E (pt) Composicao de ibuprofeno
FI974241A0 (fi) BPM-15 -koostumukset
DE69819522D1 (de) Waschmittelzusammensetzungen
ID16251A (id) Komposisi-komposisi pembasmi kuman
PT907364E (pt) Composicao farmaceutica de libertacao sustida
NO20002279D0 (no) Sammensetninger av lipidsenkende midler
DE69826138D1 (de) Parfümzusammensetzung
MA24799A1 (fr) Compostions detergentes
PT1014987E (pt) Composicoes orais de levosimendano
PT1028718E (pt) Formulacao de libertacao prolongada
ID22764A (id) Komposisi pembersih abrasif-semprot
NO981568D0 (no) Randtennings-tennsatssammensetninger
DE69806930D1 (de) Waschmittelzusammensetzungen
DE69617029D1 (de) Organoton-zusammensetzungen
ID25650A (id) Komposisi-komposisi sampo
NO993460D0 (no) Paroxetine-preparater
ID24374A (id) Komposisi-komposisi parenteral alatrofloksasin
ID18832A (id) Komposisi insektisida
ID20699A (id) Komposisi pelembut kain
ID24336A (id) Komposisi pelembut kain

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application